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Chloroform, methanol and aqueous extracts of Penstemon roseus and Senna crotalarioides were investigated for their anti-inflammatory and antioxidant 
properties. The aqueous extract had no activity on TPA-induced ear edema, but the chloroform and methanol extracts of both plants caused a significant 
inhibition of the edema. The chloroform extracts showed activity on carrageenan-induced paw edema and mouse ear edema induced by multiple topical 
applications of TPA, and only P. roseus (dose of 100 mg/kg) exhibited anti-arthritic activity. The methanol extracts of P. roseus and  S. crotalarioides had the 
most activity in the DPPH and reducing power tests. The LD50 values in mice of both chloroform extracts were considerate as slight acute toxic and higher 
than the doses used in this study. 
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Resumen 
Las propiedades antiinflamatorias y antioxidantes de los extractos de cloroformo, metanol y agua de Penstemon roseus y Senna crotalarioides fueron 
investigadas. El extracto acuoso no tuvo actividad sobre el edema auricular inducido con TPA, pero el extracto de cloroformo y etanol de ambas plantas 
inhibieron significativamente el edema.  El extracto de cloroformo mostró actividad sobre el edema plantar inducido con carragenina y el edema auricular en 
ratón inducido por múltiples aplicaciones de TPA, y solo P. roseus y S. crotalarioides tuvieron la mejor actividad en las pruebas de DPPH y poder reductor. 
Los valores de la DL50 en ratón de ambos extractos de cloroformo son considerados con ligera toxicidad aguda  y mayores que las dosis empleadas en el 
estudio. 
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INTRODUCTION 
Penstemon roseus (Sweet.) G. Dom 
(Scrophulariaceae) is commonly known as jarritos, 
chulpa or cantaritos. It is a rounded herb up 40 to 60 
cm tall with lanceolate leaves that are 3 to 9 cm long 
with very abundant red flowers; it grows in quercus, 
pinus and abies forests. In traditional medicine, this 
plant is used to heal infected wounds, insect bites and 
as an insecticide (Villavicencio et al., 2002). 
Senna crotalarioides Kunth (Fabaceae) is a 
plant puberolent that grows in the Nuevo León and 
San Luis Potosi States of Mexico. In traditional 
medicine, it is used to treat different types of 
inflammation. 
Is well known that oxygen and nitrogen 
reactive species are produced in all mammalian cells 
as the result of normal cellular metabolism, and these 
species play roles in normal physiological processes, 
in protection against pathogens, cellular signaling 
pathways and the regulation of vascular tone (Valko et 
al., 2007). These species play a crucial role in the 
development of different forms of damage in various 
human diseases (cancer, aging, neurodegenerative 
disease, malaria and pathological events in living 
organisms) (Gutteridge, 1994; Villamor et al., 2004). 
The objective of this research was to validate the use 
of S. crotalarioides and P. roseus in traditional 
medicine; therefore, the anti-inflammatory and 
antioxidant properties and the acute toxicity of extracts 
of these plants in mice and rats were evaluated using 
various experimental models. This is the first attempt 
to observe whether both plant extracts have biological 
activity. 
 
MATERIALS Y METHODS 
Solvent and Reagents 
Chloroform, ethanol and water were reactive grade. 
The reagents were Sigma-Aldrich. Indomethacin 99% 
TLC, carrageenan lamda type IV, Phorbol 12-
myristate 13-acetate 99% TLC (TPA), Freunds 
adjuvant complete.  
 
Plant material 
S. crotalarioides was collected in the Las Comadres 
Municipality of Guadalcazar, San Luis Potosi State, 
Mexico in August 2007, and P. roseus was collected in 
El Chico, Hidalgo State, Mexico in September 2006. 
The taxonomic identification of the plants was 
confirmed by taxonomist José García Pérez. Voucher 
specimens (SPLM43012 and SPLM43013 
respectively) have been deposited in the Isidro 
Palacios Herbarium of the Universidad Autónoma de 
San Luis Potosí.  
The extracts were obtained by successive and 
exhaustive maceration to temperature of ebullition 
with chloroform, ethanol and water. 
 
Animals 
Male Wistar Rats (150-200 g) and male mice of the 
CD1 strain (20-25 g) from the Universidad Autónoma 
Metropolitana-Xochimilco animal facility were housed 
in isolated cages at 24 °C under a light-dark cycle of 
12 h:12 h, and were maintained with food (Purina) and 
water ad libitum. The animals were performed 
according to the current procedure for the care of 





a) 12-O-tetradecanoylphorbol 13-acetate (TPA)-
induced mouse ear edema 
Edema was induced according to the method described 
by Young and De Young, 1989. A solution of 2.5 g 
of 12-O-tetradecanoylphorbol 13-acetate (TPA) in 25 
L of acetone was topically applied to groups of male 
mice of the CD1 strain (20-22 g) on both the inner and 
outer surfaces of the right (W) and left ears (W’). 
Administration of S. crotalarioides and P. roseus 
extracts (2 mg/ear) and indomethacin (2 mg/ear) 
dissolved in acetone was performed 30 minutes after 
TPA administration to the right ear. The left ear was 
treated with the vehicle (acetone) only. The extent of 
inflammation in the control group was determined as 
the difference in the weight of the TPA-inflamed ear 
and the vehicle-treated ear (Wo). In all groups, the 
edema was allowed to develop for 6 hours. Then, the 
animals were sacrificed by cervical dislocation, and 
plugs (diameter of 6 mm) of the central portion were 
taken from both ears and weighed. The reduction of 
the edema in the mice treated with indomethacin or the 










b) Carrageenan-induced rat paw edema 
The carrageenan-induced edema assay was carried out 
according to Winter et al., 1962. Groups of five rats 
were injected with 100 L of a 1 % carrageenan 
solution in the sub-plantar region of the left hind paw. 
A test group of rats was treated orally with 50, 100, 
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200 or 400 mg/kg of one of the extracts 1 h prior to 
carrageenan injection. 
At the same time, the control group received 
the vehicle (1 % Tween 80), while the standard 
reference group was treated with a solution of 
indomethacin (8 mg/kg). The paw volume was 
measured by the volume displacement method using a 
plethysmometer (Ugo Basile, Milan) at 1, 2, 3, 4 and 5 
h after carrageenan administration. The inhibitory 
activity was calculated according to the following 













c) Adjuvant-induced arthritis in rats 
The arthritic syndrome was induced in groups of seven 
rats (150-200 g) according to the method of adjuvant-
carrageenan-induced inflammation (ACII) (Rocha et 
al., 2002) by injections of 0.1 mL of Freund’s 
complete adjuvant intradermally at the base of the tail. 
The experimental group received chloroform extracts 
of P. roseus (100 mg/kg) or S. crotalarioides (50 
mg/kg) in 1.0 % Tween 80, and the reference group 
received indomethacin (4 mg/kg) in the same delivery 
system. The control group received only vehicle. The 
animals were administered with indomethacin, extracts 
or vehicle daily in the morning for 6 to 10 days after 
adjuvant inoculation. On the sixth day, after one hour 
of drug administration, a suspension of 0.1 mL of 
carrageenan was injected in the subplantar region of 
the left hind paw of each rat. The paw volume was 
measured by the volume displacement method using a 
plethysmometer. These measurements were made 
before the adjuvant injection and were repeated again 
6 days later at 3 and 5 h (acute phase) and were 
continued for 24 to 96 h after the carrageenan 
injection. The edema volume is expressed as the 
difference found in the left hind paw compared with 
the right hind paw. The inhibition of edema was 
calculated for each animal group in comparison with 
the control group. 
 
d) Mouse ear edema induced by multiple topical 
applications of TPA 
A solution of 2.5 g of 12-O-tetradecanoylphorbol 13-
acetate (TPA) in 25 L of acetone was topically 
applied to groups of male mice of the CD1 strain (20-
22 g) on both the inner and outer surfaces of the right 
(W) and left ear (W’) 5 times over 10 days (Gábor, 
2000). Topical administration of the extract (2 mg/ear) 
or indomethacin (0.5 mg/ear) dissolved in acetone on 
the left ear was performed 30 minutes after TPA 
administration. The extent of inflammation in the 
control group was determined as the difference of the 
weight between the TPA-inflamed ear and the vehicle-
treated ear (Wo). All animals were sacrificed by 
cervical dislocation after 10 days, and plugs (diameter 
of 6 mm) of the central portion were taken from both 
ears and weighed. The reduction of edema in the mice 
treated with indomethacin or the extract was expressed 













a) Free Radical Scavenging by the use of DPPH 
Radical. 
The DPPH radical scavenging capacity of each extract 
was determined according to the method of Brand-
Williams et al., 1995, as modified by Miliauskas et al., 
2004. DPPH radicals have an absorption maximum at 
517 nm, which disappears upon reduction by an 
antioxidant compound. The DPPH radical solution in 
methanol (9 x 10
-5
 M) was freshly prepared, and 2.9 
mL of this solution was mixed with 100 µL of 
solutions of plant extracts at concentrations of 33, 16.5 
and 8.25 µg/mL. The samples were incubated for 30 
min at 37 °C in a water bath, and the decrease in 
absorbance at 517 nm was measured (AE). A blank 
sample containing 100 µL of methanol in the DPPH 
radical solution was prepared daily, and its absorbance 
was measured (AB). The radical scavenging activity 
was calculated using the following formula: 
 
% inhibition = 1-[(AB – AE)/AB] x 100 
 
b) Determination of Total Phenolic Content 
The total phenolic concentration was determined using 
the Folin-Ciocalteu reagent according to Spanos and 
Wrosltad [12]. To 50 µL of each sample (three 
replicates), 2.5 mL of a 1/10 dilution of Folin-
Ciocalteu´s reagent and 2 mL of Na2CO3 (7.5 %, w/v) 
were added and incubated at 45 °C for 15 min. The 
absorbance of all samples was measured at 765 nm 
using a UV-Vis spectrophotometer. The results are 
expressed as milligrams of gallic acid equivalent per 
gram of dry weight extract (mg GAE/g dw). 
García Rodriguez et al Anti-inflammatory evaluation and antioxidant potential of S. crotalariodes and P roseus  
 
Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromáticas/26 
 
 
c) Determination of Reducing Power 
The reducing power was determined according to the 
method described by Oyaizu, 1986. A 0.125 mL 
aliquot of various concentrations of extract (33, 16.5 
and 8.25 µg/mL) was mixed with 1.25 mL of 200 mM 
sodium phosphate buffer (pH 6.6) and 1.25 mL of 1% 
potassium ferricyanide. The mixture was then 
incubated at 50 °C for 20 min. After 1.25 mL of 10% 
trichloroacetic acid (w/v) were added, the mixture was 
centrifuged at 650g for 10 min. A 2.5 mL aliquot of 
the upper layer was mixed with 5 mL of distilled water 
and 1 mL of 0.1% ferric chloride, and the absorbance 
at 700 nm was measured. The obtained observance 




The extract was orally administered as a single dose to 
groups of mice (n = 3) at different concentrations 
(1000-5000 mg/kg). The range of doses used in mice 
followed the method of Lorke, 1983. After 
administration, the animals were observed under open-
field conditions for a 72 h period. The number of 
animal deaths and signs of clinical toxicity were 
recorded during the first 24 h. The median lethal dose 
(LD50) and 95 % confidence limits were calculated by 
the method of Litchfield and Wilcoxon, 1949. 
 
Statistical analysis 
Statistical analysis was performed using the Student’s 
t-test (P < 0.05), while ANOVA followed by Dunett’s 
multiple comparison test was used in order to compare 
more than two groups.   
 
RESULTS AND DISCUSSION 
The yields of the chloroform, methanol and aqueous 
extracts of Senna crotalarioides and Penstemon roseus 
are shown in Table 1. The chloroform extracts 
provided the highest yield. 
 
Table 1. Yield of the extracts of S. crotalarioides and P. roseus 
Extracts Yield (%) 
Senna crotalarioides  
        Chloroform 2.20 
        Methanol 1.24 
        Aqueous 2.07 
Penstemon roseus  
       Chloroform  5.06 
       Methanol 4.90 
       Aqueous 3.95 
 
  
Table 2 shows the inhibitory effects of the chloroform, 
methanol and aqueous extracts of S. crotalarioides and 
P. roseous on TPA-induced ear edema. It is evident 
that the aqueous extracts of both plants at doses of 2 
mg/ear did not produce a significant effect; however, 
the methanol and chloroform extracts of both plants 
had significant activity, and we decided to follow-up 
with both chloroform extracts, so the anti-
inflammatory effect was tested in models of acute and 
chronic inflammation. 
 
Table 2. Effects of the topical application of indomethacin and 
chloroform, methanol and aqueous extracts of S. crotalarioides and 









  (%) 
Control 0 12.27±0.35 0 
S. crotalarioides    
Chloroform 2 7.82±0.48* 36.27±3.93 
Methanol 2 8.26±0.44* 32.68±3.61 
Aqueous 2 8.70±0.43 29.09±0.87 
P. roseus    
Chloroform 2 6.95±0.36* 43.36±1.23 
Methanol 2 7.77±0.50* 36.67±3.71 
Aqueous                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   2 8.91±0.64 27.38±2.99
Indomethacine 2 6.28±0.56* 48.82±5.70 
Results are mean  S.E.M., * extract and the reference, p  0.05 vs 
control according T Student’s test. 
 
The results obtained with the chloroform extracts of S. 
crotalarioides (CSC) and P. roseus (CPR) on mouse 
ear edema induced by multiple topical applications of 
TPA at a dose of 2 mg/ear (Table 3) demonstrated that 
both extracts exhibited anti-inflammatory effects.   
The activity of the chloroform extracts of S. 
crotalarioides (64.92 %) was similar to that of 
indomethacin at a dose of 0.5 mg/ear (62.74 %), and 
CPR showed a minor effect (42.30 %). 
 
Table 3.  Effect of the chloroform extracts of  S. crotalarioides and  









Inhibition      
(%) 
Control 0 10.52±0.77 0 
S. crotalarioides 2 3.69±0.27* 64.92 
P. roseus 2 6.07±0.51* 42.30 
Indomethacin 0.5 3.92±0.44* 62.74 
Results are mean  S.E.M., * extracts and the reference p  0.05 vs 
control according T Student’s test. 
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Table 4. Effect of chloroform extracts of S. crotalarioides and P. roseus on paw edema of rats induced with carrageenan. 
 
Results indicate percent reduction in paw volume compared with the control group treat only carrageenan±standard error. n= 7. Dunnett test 
* p< 0.05.  N.E= not effect. 
 
The pronounced inflammation induced by 
TPA when administered topically is thought to be 
mediated by protein kinase C and the stimulation of 
phospholipase A2 (Füstenberger et al., 1981), which 
results in the release of arachidonic acid and 
prostaglandin E2 (Ashendel and Boutwell, 1982). 
Thus, both phospholipase A2 and cyclooxygenase 
inhibitors are effective in these models, and CSC and 
CPR may interfere with these mediators to inhibit 
TPA-induced inflammation. 
Both extracts, tested in vivo, showed 
significant activity on carrageenan-induced 
inflammation with respect to the control group (Table 
4). CSC showed no activity at doses of 100, 200 and 
400 mg/kg; however, a dose of 50 mg/kg produced a 
significant reduction of 55.8 % after 1.0 h, and the 
effect was unchanged for 3 h, decreased after 4.0 h 
(36.0 %), and was eliminated after 5 h. CPR showed 
the best effect at a dose of 200 mg/kg 3 h after the 
administration (52.3 %).  
It is well known that leukocyte migration to 
injured tissue is an important aspect of the 
inflammatory process. The release of several 
mediators of the flogistic response, such as histamine 
and serotonin, are responsible for the immediate 
inflammation response (Crunkhon and Meacock, 
1971), whereas kinins and prostaglandins mediate the 
prolonged response (Brito and Antonio, 1998). On the 
other hand, some plant constituents can significantly 
inhibit the biosynthetic pathways of inflammation 
mediators (Speroni et al., 2005). Currently, the 
hypothesis is that both extracts can significantly 
inhibit the production of these mediators. 
Rheumatoid arthritis is a chronic progressive 
autoimmune inflammatory disease of unknown 
etiology and complex multifactorial pathogenesis 
characterized by irreversible erosive synovitis, 
resulting in deformity, loss of joint space and function, 
and bone destruction (Rassol amd Varalakshmi, 2007). 
Increased edema in rat hind paw injected with 
carrageenan has an acute and a prolonged phase and 
has been proposed as a suitable and simple model 
system for evaluating the anti-inflammatory activity 
and therapeutic effects of treatment (Billiau and 
Matthys, 2001; Lee et al., 2004). The above results 
showed that CSC had no activity on adjuvant-induced 
arthritis in rats (Table 5). However, CPR exhibited an 
anti-arthritic effect in the acute phase. After 24 h of 
oral administration of the extract at doses of 100 
mg/kg, the inhibition was 69.17 %, which was similar 
to that obtained in animals treated with indomethacin 
(4 mg/kg), but the effect decreased after 48 h (32.45 
%) and had no effect after 72 h.  
 
Table 5.  Effect of the chloroform extracts of S. crotalarioides and 
P. roseus on rat treatment with Freud adjuvant and paw edema 
induced with carrageenan. 
Time  
(h) 
Treatment and % Inhibition 
Control  S.crotalarioides 
 50 mg/kg 
P. roseus    
100 mg/kg 
Indomethacin 
 4 mg/kg 
3  0 N.E. N.E. 34.10±6.43 
5  0 N.E. N.E. 45.95±9.62* 
24  0 N.E. 69.17±2.14* 75.53±4.59* 
48  0 N.E. 32.45±7.56 48.10±3.46* 
72  0 N.E. N.E. 55.03±8.77* 
96  0 N.E N.E. 36.89±9.25 
Results indicate percent reduction in paw volume compared with 
the control group treat only carrageenan. ± standard error of 







Paw oedema  (% Inhibition) 
1h 2h 3h 4h 5h 
Control   (0)  
 
 (0)  
 
 (0)  
 




S. crotalarioides 400  N.E N.E N.E. N.E. N.E. 
 200  N.E. N.E. N.E. N.E. N.E. 
 100  N.E. N.E. N.E. N.E. N.E. 
 50  55.78±12.07* 62.82±17.26* 50.92±12.76* 41.67±15.89 28.03±10.84 
P.  roseus 400  N.E. 31.41±4.26 37.61±4.26 28.80±10.90 N.E. 
 200  20.83±5.27 29.30±4.02 52.31±4.47* 40.00±3.75 41.20±3.42 
 100  38.31±8.53 43.69±9.38* 36.92±7.89 34.80±4.33 34.09±3.51 
 50  47.37±11.67 26.92±6.08 40.17±14.74 35.66±6.64 N.E. 
Indomethacin 8  N.E. 26.92±7.28 57.40±4.58* 56.00±4.03* 56.29±5.22* 
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The antioxidant capacity of the extracts of 
Senna crotalarioides and Penstemon roseus was 
determined by the radical scavenging based on the 
DPPH assay. The methanol extracts of S. 
crotalarioides and P. roseus were most active, with 
inhibitory concentrations (IC50) of 23.04±0.22 and 
19.27±0.37 µg/mL, respectively; these values were 
higher than that of ascorbic acid, at 0.58±0.02 µg/mL. 
The total phenol content was evaluated and the 
aqueous extract of S. crotalarioides showed the major 
concentration of these kinds of compounds 
(253.37±7.65 µg/mL). This amount represents twice 
the values obtained with every extract processed. The 
reducing power of methanol extracts showed the major 
activity with respect to ascorbic acid as a reference 
(13.99±4.37 and 14.98±0.69 % for S. crotalarioides 
and P. roseus, respectively) (Table 6). The antioxidant 
capacity of different medicinal plants and herbs has 
been linked to in vivo protection against oxidative 
stress in numerous studies (Prior et al., 2005), but has 
rarely been associated with an anti-inflammatory 
capacity (Jensen et al., 2008). 
 
Table 6. Antioxidant capacity of the extracts of S. crotalarioides 
and P. roseus 
Treatment DPPH Total phenols  Reducing 
power 
(%) 
S.crotalarioides    
Chloroform 88.62±0.86 69.87±1.35 5.84±0.12 
Methanol 23.04±0.22 137.52±4.10 13.99±4.37 
Aqueous 43.29±1.16 253.37±7.65 6.53±0.13 
P.  roseus    
Chloroformº  270.32±36.94 115.67±8.75 1.87±0.23 
Methanol 19.27±0.37 126.82±6.00 14.98±0.69 
Aqueous 171.53±10.42 120.12±10.00 5.61±0.66 
Quercetin - 782.92±36.80 7.63±1.11 
Ascorbic acid 0.58±0.02 - 100 
Data are expressed as mean ± error standar (n=3). DPPH radical 
solution in methanol (9 x 10-5 M, 35.48 µg/mL) using (33µg/mL) 
of plant extract and ascorbic acid (5 µg/mL). Total phenols 
expressed in mgs. of Gallic acid equivalent per g of sample 
(mgGAE/g). Reducing power is expressed with respect to ascorbic 
acid (33µg/mL).   
 
In Table 7, the LD50 of the chloroform extracts 
of CSC (2150 mg/kg) and CPR (3,800 mg/kg) in mice 
are shown. The values obtained are considerate as 
slight acute toxic and both doses are higher than those 






Table 7. Evaluation of LD50 of the chloroform extracts of S. 
crotalarioides and  P. roseus in mice. 
 
Chloroform extracts LD50 (mg/kg) 
Senna crotalarioides 2,150 
Penstemon roseus 3,800 
 
CONCLUSIONS 
Senna crotalarioides and Penstemon roseus or their 
constituents could represent, in the near future, a new 
therapeutic option for the treatment of inflammatory 
diseases, and in the case of P. roseus, might be 
important in the treatment of chronic progressive 
autoimmune inflammatory diseases.  Both plants also 
have antioxidant capacity, and the activities were 
comparable to those of known antioxidant ascorbic 
acid, which has been linked to protection against 
oxidative stress. 
S. crotalarioides and P. roseus did not present 
acute toxicity at the studied doses. Experiments are in 
progress to identify the active compounds and to 
further evaluate the molecular mechanism through 
which these compounds exert their anti-inflammatory 
and antioxidant properties.  
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